Literature DB >> 19402225

Increased arterial stiffness in familial combined hyperlipidemia.

Martijn C G J Brouwers1, Koen D Reesink, Marleen M J van Greevenbroek, Jan M Meinders, Carla J H van der Kallen, Nicolaas Schaper, Arnold P G Hoeks, Coen D A Stehouwer.   

Abstract

OBJECTIVE: The current study was conducted to investigate whether greater arterial stiffening is already present in normolipidemic relatives of patients with familial combined hyperlipidemia (FCHL), as compared with healthy controls, and to establish the factors that are associated with arterial stiffness in comparison with markers of atherosclerosis.
METHODS: Seventy-seven FCHL patients, 121 normolipidemic relatives and 72 spouses (controls) underwent ultrasound examination of the common carotid artery to determine the presence of plaques and the degree of arterial stiffness, expressed as stiffness index alpha.
RESULTS: Age-adjusted and sex-adjusted analyses revealed that the arterial stiffness index alpha and prevalence of plaques were higher in normolipidemic relatives when compared with spouses, but lower than in FCHL patients (P<0.05). Additional adjustments for visceral obesity, smoking, plasma glucose, insulin, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, pulse frequency and use of lipid-lowering or antihypertensive medication did not affect the results for arterial stiffness, whereas the adjusted prevalence of atherosclerosis was markedly lowered in FCHL patients. Logistic regression analyses demonstrated that age, male sex, pulse frequency and low-density lipoprotein cholesterol were significant independent determinants of atherosclerotic plaques. In contrast, only age and FCHL family status, that is, belonging to an FCHL family or not, contributed to arterial stiffness.
CONCLUSION: Arterial stiffening and atherosclerosis appear to be greater in patients who are prone to develop FCHL, that is, normolipidemic FCHL family members, as compared with controls. These findings may add to our understanding of the increased prevalence of cardiovascular complications in not only FCHL patients, but also their siblings and offspring.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19402225     DOI: 10.1097/hjh.0b013e32832991fa

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Differential impact of familial hypercholesterolemia and combined hyperlipidemia on vascular wall and network remodeling in mice.

Authors:  Phoebe A Stapleton; Adam G Goodwill; Milinda E James; Alexandre C D'Audiffret; Jefferson C Frisbee
Journal:  Microcirculation       Date:  2010-01       Impact factor: 2.628

2.  Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults.

Authors:  Elaine M Urbina; Philip R Khoury; Connie E McCoy; Lawrence M Dolan; Stephen R Daniels; Thomas R Kimball
Journal:  Pediatrics       Date:  2013-03-04       Impact factor: 7.124

3.  Influence of low high-density lipoprotein cholesterol on arterial stiffening and left ventricular diastolic dysfunction in essential hypertension.

Authors:  Dong-Mei Miao; Ping Ye; Wen-Kai Xiao; Peng Gao; Jin-Yao Zhang; Hong-Mei Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-14       Impact factor: 3.738

4.  Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia.

Authors:  Giuseppe Mandraffino; Carmela Morace; Maria Stella Franzè; Veronica Nassisi; Davide Sinicropi; Maria Cinquegrani; Carlo Saitta; Riccardo Scoglio; Sebastiano Marino; Alessandra Belvedere; Valentina Cairo; Alberto Lo Gullo; Michele Scuruchi; Giovanni Raimondo; Giovanni Squadrito
Journal:  Biomedicines       Date:  2022-07-22

5.  Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate.

Authors:  Arrigo F G Cicero; Giuseppe Derosa; Pamela Maffioli; Alessandra Reggi; Elisa Grandi; Claudio Borghi
Journal:  Arch Med Sci       Date:  2013-04-09       Impact factor: 3.318

6.  Incidence of type 2 diabetes in familial combined hyperlipidemia.

Authors:  Martijn C G J Brouwers; Jacqueline de Graaf; Nynke Simons; Steven Meex; Sophie Ten Doeschate; Shadana van Heertum; Britt Heidemann; Jim Luijten; Douwe de Boer; Nicolaas Schaper; Coen D A Stehouwer; Marleen M J van Greevenbroek
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.